Logo

Glen Research Inks Marketing License Pact with TriLink

Jun 24, 2009

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that it has signed up Glen Research Corporation to sell its CleanAmp PCR solution for use in the production of CleanAmp Primers, under a new license agreement.

By selling the CleanAmp Amidites solution, in which the primer components of the PCR reaction mix, Glen Research's customers will be able to make the CleanAmp Primers in-house, the company said.

Sterling, Virginia-based Glen Research offers a range of phosphoramidites and solid supports for chemical synthesis, modification, and purification of DNA and RNA oligonucleotides.

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.